Subclinical ductal carcinoma in situ of the breast: Treatment with conservative surgery and radiotherapy

Maurizio Amichetti, Orazio Caffo, Antonella Richetti, Giampaolo Zini, Alberto Rigon, Michele Antonello, Mario Roncadin, Francesca Coghetto, Riccardo Valdagni, Stefano Fasan, Sergio Maluta, Adriano Di Marco, Stefano Neri, Cristiana Vidali, Gino Panizzoni, Cynthia Aristei

Research output: Contribution to journalArticle

Abstract

Aims and background: In spite of the fact that ductal carcinoma in situ (DCIS) of the breast is a frequently encountered clinical problem, there is no consensus about the optimal treatment of clinically occult (i.e,, mammographic presentation only) DCIS. Interest in breast conservation therapy has recently increased. Few data are available in Italy on the conservative treatment with surgery and adjuvant postoperative radiotherapy. Methods: A retrospective multi-institutional study was performed in 15 Radiation Oncology Departments in northern Italy involving 112 women with subclinical DCIS of the breast treated between 1982 and 1993. Age of the patients ranged between 32 and 72 years (median, 50 years). All of them underwent conservative surgery: quadrantectomy in 89, tumorectomy in 11, and wide excision in 12 cases. The most common histologic subtype was comedocarcinoma (37%). The median pathologic size was 10 mm (range 1 to 55 mm). Axillary dissection was performed in 83 cases: all the patients were node negative. All the patients received adjunctive radiation therapy with 60Co units (77%) or 6 MV linear accelerators (23%) for a median total dose to the entire breast of 50 Gy (mean, 49.48 Gy; range, 45-60 Gy). Seventy-six cases (68%) received a boost to the tumor bed at a dose of 8-20 Gy (median 10 Gy) for a minimum tumor dose of 58 Gy. Results: At a median follow-up of 66 months, 8 local recurrences were observed, 4 intraductal and 4 invasive. All recurrent patients had a salvage mastectomy and are alive and free of disease at this writing. The 10-year actuarial overall, cause-specific, and recurrence-free survival was of 98.8%, 100%, and 91%, respectively. Conclusions: The retrospective multicentric study, with a local control rate of more than 90% at 10 years with 100% cause-specific survival, showed that conservative surgery and adjuvant radiation therapy is a safe and efficacious treatment for patients with occult, non-palpable DCIS.

Original languageEnglish
Pages (from-to)488-493
Number of pages6
JournalTumori
Volume85
Issue number6
Publication statusPublished - Nov 1999

Keywords

  • Breast cancer
  • In situ ductal carcinoma
  • Mammography
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Subclinical ductal carcinoma in situ of the breast: Treatment with conservative surgery and radiotherapy'. Together they form a unique fingerprint.

  • Cite this

    Amichetti, M., Caffo, O., Richetti, A., Zini, G., Rigon, A., Antonello, M., Roncadin, M., Coghetto, F., Valdagni, R., Fasan, S., Maluta, S., Di Marco, A., Neri, S., Vidali, C., Panizzoni, G., & Aristei, C. (1999). Subclinical ductal carcinoma in situ of the breast: Treatment with conservative surgery and radiotherapy. Tumori, 85(6), 488-493.